{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:12:51Z","timestamp":1791238371164,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Sweat-gland carcinoma with neuroendocrine differentiation (SCAND) was recently proposed as a new cutaneous adnexal neoplasm with neuroendocrine differentiation; however, its genetics are not well known. Herein, we performed clinicopathologic and genetic analyses of 13 SCAND cases and 5 control cases of endocrine mucin-producing sweat gland carcinoma (EMPSGC). The SCAND group included 11 males and 2 females with a median age of 68 years (range, 50 to 80\u00a0y). All SCAND lesions occurred in the ventral trunk or genital area. Of the 13 SCAND cases, 9 and 5 exhibited lymph node and distant metastases, respectively. Three (23.1%) patients with SCAND died of the disease. In contrast, neither metastasis nor mortality was confirmed in the EMPSGC cases. Immunoexpression of the androgen receptor, c-Myb, and MUC2 was limited in SCAND, whereas EMPSGC frequently expressed these immunomarkers. <jats:italic toggle=\"yes\">GATA3<\/jats:italic> P409Afs*99 extension mutations were detected in 7 (53.8%) of the 13 SCAND cases, using Sanger or panel sequencing. All 7 SCAND cases with <jats:italic toggle=\"yes\">GATA3<\/jats:italic> mutations were located in the genital, inguinal, or lower abdominal regions, whereas 5 of the other 6 SCAND cases were located in the anterior upper to mid-trunk. No <jats:italic toggle=\"yes\">GATA3<\/jats:italic> mutations were detected in the EMPSGC cases (0\/5, 0%). These clinicopathologic and genetic findings support SCAND as a tumor entity distinguishable from EMPSGC. In addition, the characteristic frameshift extension mutations in <jats:italic toggle=\"yes\">GATA3<\/jats:italic> contribute to the establishment of the tumor-type concept of SCAND.<\/jats:p>","DOI":"10.1097\/pas.0000000000002195","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T14:00:06Z","timestamp":1707919206000},"page":"528-537","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Recurrent GATA3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation"],"prefix":"10.1097","volume":"48","author":[{"given":"Keisuke","family":"Goto","sequence":"first","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology"},{"name":"Department of Diagnostic Pathology, Osaka National Hospital, Osaka"},{"name":"Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto"},{"name":"Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital"},{"name":"Department of Pathology, Itabashi Central Clinical Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kiniwa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Kukita","sequence":"additional","affiliation":[{"name":"Laboratory of Genomic Pathology, Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ohe","sequence":"additional","affiliation":[{"name":"Department of Dermatologic Oncology, Osaka International Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Hiraki","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Hishima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Takai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hyogo Cancer Center, Akashi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology and Cytology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41379-021-00921-8","article-title":"Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis","volume":"35","author":"Goto","year":"2022","journal-title":"Mod Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/DAD.0000000000000657","article-title":"Low-grade neuroendocrine carcinoma of the skin (primary cutaneous carcinoid tumor) as a distinctive entity of cutaneous neuroendocrine tumors: a clinicopathologic study of 3 cases with literature review","volume":"39","author":"Goto","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"R3-20250608","first-page":"9513","article-title":"A case of sweat-gland carcinoma with neuroendocrine differentiation","volume":"15","author":"Koizumi","year":"2022","journal-title":"Dermatol Rep"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/DAD.0000000000002262","article-title":"Sweat gland carcinoma with neuroendocrine differentiation of the areola as a potential clinicopathologic mimicker of male breast carcinoma and syringocystadenocarcinoma papilliferum","volume":"44","author":"Bun","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/00000478-199712000-00014","article-title":"Endocrine mucin-producing sweat gland carcinoma: a cutaneous neoplasm analogous to solid papillary carcinoma of breast","volume":"21","author":"Flieder","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/01.pas.0000170348.40057.60","article-title":"Endocrine mucin-producing sweat gland carcinoma: twelve new cases suggest that it is a precursor of some invasive mucinous carcinomas","volume":"29","author":"Zembowicz","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/cup.12314","article-title":"Endocrine mucin-producing sweat gland carcinoma occurring on extra-facial site: a case report","volume":"41","author":"Tsai","year":"2015","journal-title":"J Cutan Pathol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cup.12424","article-title":"Considerations before accepting an extra-facial location of endocrine mucin-producing sweat gland carcinoma","volume":"42","author":"Fernandez-Flores","year":"2015","journal-title":"J Cutan Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/cup.13290","article-title":"Endocrine mucin-producing sweat gland carcinoma: a clinicopathologic, immunohistochemical, and molecular analysis of 11 cases with emphasis on MYB immunoexpression","volume":"45","author":"Held","year":"2018","journal-title":"J Cutan Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cup.13308","article-title":"Endocrine mucin-producing sweat gland carcinoma: a study of 11 cases with molecular analysis","volume":"45","author":"Qin","year":"2018","journal-title":"J Cutan Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/PAS.0000000000001462","article-title":"An update on endocrine mucin-producing sweat gland carcinoma: clinicopathologic study of 63 cases and comparative analysis","volume":"44","author":"Agni","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/cup.13983","article-title":"Endocrine mucin-producing sweat gland carcinoma and associated primary cutaneous mucinous carcinoma: review of the literature","volume":"48","author":"Au","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/DAD.0000000000002132","article-title":"Endocrine mucin-producing sweat gland carcinoma: emerging evidence of multicentric cutaneous origin and occasional concurrence with analogous breast tumors","volume":"44","author":"Ravi","year":"2022","journal-title":"Am J Dermatopathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12105-021-01353-1","article-title":"Endocrine mucin producing sweat gland carcinoma with metastasis to parotid gland: not as indolent as perceived?","volume":"16","author":"Sarangi","year":"2022","journal-title":"Head Neck Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jdcr.2023.03.012","article-title":"Endocrine mucin-producing sweat gland carcinoma with regional metastases in an African American female","volume":"36","author":"Mattia","year":"2023","journal-title":"JAAD Case Rep"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cyt.13239","article-title":"Cytological findings in a case of endocrine mucin-producing sweat gland carcinoma with metastasis to salivary glands","volume":"34","author":"Chang","year":"2023","journal-title":"Cytopathology"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/DAD.0000000000001664","article-title":"Neuroendocrine differentiation of skin tumors: a comprehensive review","volume":"42","author":"Hamie","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jaad.2020.11.073","article-title":"Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin.","volume":"86","author":"Mathew","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/cas.14754","article-title":"Establishment and implementation of cancer genomic medicine in Japan","volume":"112","author":"Mukai","year":"2021","journal-title":"Cancer Sci"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"e1006279","DOI":"10.1371\/journal.pgen.1006279","article-title":"Gain- and loss-of-function mutations in the breast cancer GATA3 result in differential drug sensitivity","volume":"12","author":"Mair","year":"2016","journal-title":"PLoS Genet"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cge.13063","article-title":"Mutations screening of 10 cancer susceptibility genes in unselected breast cancer patients.","volume":"93","author":"Xie","year":"2018","journal-title":"Clin Genet"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ccell.2018.11.006","article-title":"Loss of the FAT1 tumor suppressor promotes resistance to CDK4\/6 inhibitors via the Hippo pathway","volume":"34","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1038\/s41467-018-05914-x","article-title":"The prognostic effects of somatic mutations in ER-positive breast cancer","volume":"9","author":"Griffith","year":"2018","journal-title":"Nat Commun"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41588-018-0287-5","article-title":"Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor-directed therapies","volume":"51","author":"Nayar","year":"2019","journal-title":"Nat Genet"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1093\/hmg\/ddu111","article-title":"Classification of a frameshift\/extended and s top mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation","volume":"23","author":"Busch","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/2159-8290.CD-20-1066","article-title":"ZFTA-RELA dictates oncogenic transcriptional programs to drive aggressive supratentorial ependymoma","volume":"11","author":"Arabzade","year":"2021","journal-title":"Cancer Discov"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"544","DOI":"10.25259\/IJDVL_1260_20","article-title":"Endocrine mucin-producing sweat gland carcinoma: reappraisal of patient demographics and tumour immunophenotypes","volume":"88","author":"Chuang","year":"2022","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/cup.13349","article-title":"Expression of hormone receptors, adipophilin, and GCDFP-15 in mucinous carcinoma of the skin","volume":"45","author":"Sung","year":"2018","journal-title":"J Cutan Pathol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/DAD.0000000000001990","article-title":"Utility of insulinoma-associated protein 1 (INSM1) and mucin 2 (MUC2) immunohistochemistry in the distinction of endocrine mucin-producing sweat gland carcinoma from morphologic mimics","volume":"44","author":"Quattrochi","year":"2022","journal-title":"Am J Dermatopathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:05:49Z","timestamp":1749413149000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002195","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,14]]}}}